ArticleBMC cardiovascular disorders2026
Massive hemoptysis after left atrial appendage occlusion in a patient with atrial fibrillation and left atrial appendage thrombus: a case report.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report the case of an 86-year-old male with atrial fibrillation and a persistent left atrial appendage thrombus despite prolonged oral anticoagulation therapy. The patient successfully underwent intracardiac echocardiography-guided left atrial appendage occlusion with the thrombus in situ. However, he developed a rare but serious complication-massive hemoptysis. The patient then underwent bronchial artery angiography with successful embolization of the dilated bronchial arteries. Following the procedure, the hemoptysis was effectively controlled without any sequelae, and no complications were observed during six months of follow-up.As LAAO technology becomes more widely adopted, clinicians should remain vigilant for rare but life-threatening complications and be prepared for immediate intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.